trifluoperazine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Körbel, C | 1 |
Linxweiler, M | 1 |
Bochen, F | 1 |
Wemmert, S | 1 |
Schick, B | 1 |
Meyer, M | 1 |
Maurer, H | 1 |
Menger, MD | 1 |
Zimmermann, R | 1 |
Greiner, M | 1 |
1 other study available for trifluoperazine and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Carcinoma, Squamous Cell; Cell | 2018 |